Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (271-280 of 315) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patientsD Kirn, P Mauch, K Shaffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meetingT A Lister, D Crowther, S B Sutcliffe, et al.
Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.
Cancer Treatment Reports|November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologiesK C Anderson, A T Skarin, D S Rosenthal, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Leukemia & Lymphoma|April 6, 2004
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparisonJonathan W Friedberg, Alan Fischman, Donna Neuberg, et al.
Blood|December 1, 1985
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantationJ E Sokal, M Baccarani, S Tura, et al.
Pageof 32

Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patientsD Kirn, P Mauch, K Shaffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meetingT A Lister, D Crowther, S B Sutcliffe, et al.
Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.
Cancer Treatment Reports|November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologiesK C Anderson, A T Skarin, D S Rosenthal, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Leukemia & Lymphoma|April 6, 2004
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparisonJonathan W Friedberg, Alan Fischman, Donna Neuberg, et al.
Blood|December 1, 1985
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantationJ E Sokal, M Baccarani, S Tura, et al.
Pageof 32